✦ LIBER ✦

PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow Region

✍ Scribed by Shakhanina, I.; Namazova-baranova, L.; Krasnopolskiy, V.I.; Zarochentseva, N.V.; Kozachenko, V.P.; Demarteau, N.; Shchurov, D.

Book ID: 123556263
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 69 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.1161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN23 ECONOMIC EVALUATION ON LIQUID-BASE

PCN23 ECONOMIC EVALUATION ON LIQUID-BASED CYTOLOGY IN THE CERVICAL CANCER SCREENING PROGRAM IN TAIWAN

✍ Chow, IHI; You, SL; Pwu, RF; Tang, CH 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN29 GAPS IN THE ECONOMIC EVALUATION OF

PCN29 GAPS IN THE ECONOMIC EVALUATION OF PROSTATE CANCER

✍ Y Komatsuzaki; C Atzinger; WC Lee; CL Pashos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN66 COST EVALUATION OF THE CROSS PROTE

PCN66 COST EVALUATION OF THE CROSS PROTECTION DIFFERENCE BETWEEN THE BIVALENT AND QUADRIVALENT HPV VACCINE AGAINST CERVICAL CANCER WITHIN EUROPEAN COUNTRIES

✍ S Capri; N Demarteau; B Standaert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN79 Cost Effectiveness of Human Papill

PCN79 Cost Effectiveness of Human Papillomavirus Vaccination for the Prevention of Cervical Cancer in Urban Regions of China

✍ Ross, K.D.; Cui, L.; Thomas, D.B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIH7 ECONOMIC EVALUATION OF HUMAN PAPILL

PIH7 ECONOMIC EVALUATION OF HUMAN PAPILLOMAVIRUS (HPV) VACCINATIONS IN THE PREVENTION OF CERVICAL CANCER

✍ Wan Puteh, SE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

A generally applicable cost-effectivenes

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

✍ Nadia Demarteau; Bruno Detournay; Bertrand Tehard; Abdelkader El Hasnaoui; Baudo 📂 Article 📅 2010 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 352 KB

## Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus virus (HPV) vaccination in France, using a generally applicable succinct cohort model. ## Methods A lifetime Markov cohort model, adapted to the French setting, simulate the natural history of oncogenic HPV